GME751
CGME751A12101
Phase 1 small_molecule active
Quick answer
GME751 for Melanoma is a Phase 1 program (small_molecule) at Sandoz Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sandoz Pty Ltd
- Indication
- Melanoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active